Merck to begin manufacturing COVID-19 antiviral pills in Whitby, Ont.

Merck announced on Monday that it would begin manufacturing its antiviral pill “Molnupiravir” at the Thermo Fisher Scientific plant in Whitby, Ont. The plant will be part of a network of three plants that will supply Molnupiravir to “upper and middle income countries,” said Merck Canada president and managing director Marwan Akar.

• More than 12,500 Waterloo Region kids aged 5-11 have had 1st dose of COVID-19 vaccine